Scientific Workflow Development for Pharmaceutical Applications

The contract seeks the development of validated scientific workflows focused on protein structure preparation, binding site identification, and formulation analysis, with specific alignment to the regulatory science requirements of the FDA. These workflows must be rigorously tested and documented to ensure reproducibility, accuracy, and compliance with federal standards, enabling their direct application in pharmaceutical research and product evaluation. The work is intended to support public health initiatives by enhancing the reliability of computational and analytical methods used in drug discovery and development under regulatory oversight. This subcontract is issued under the NAICS code 541690 for other scientific and technical consulting services, with performance located in Silver Spring, Maryland, 20993. The opportunity was posted on June 24, 2026, and responses are due by July 1, 2026, at 7:30 p.m. Eastern Time. The contracting entity is the Omas Strategic Buying Center – Information Technology within the Department of Health and Human Services, and no set-aside provisions have been designated. The project emphasizes technical precision and regulatory alignment, targeting specialized vendors with expertise in computational biology, pharmaceutical analytics, and FDA-compliant validation protocols.